The Latest: European Commission signs deal for virus drug
|
July 29, 2020 5:27 AM
LONDON — The European Commission says it signed a 63 million euro ($72 million) deal to secure thousands of doses of remdesavir, the only licensed experimental drug to treat people with severe COVID-19.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login